USA: Melanoma Risk Increased After Radioactive Iodine Treatment for Primary Thyroid Cancer
Patients with primary thyroid cancer who receive radioactive iodine therapy have an elevated risk for melanoma and other nonkeratinocyte skin cancers when limiting the cancer site to the head and neck, according to a study published online Sept. 19 in JAMA Network Open.
Shawheen J. Rezaei, from the Stanford University School of Medicine in California, and colleagues characterized the risk for subsequent melanoma and other nonkeratinocyte skin cancers in patients with primary thyroid malignant neoplasms. Standardized incidence ratios (SIRs) were calculated to estimate the risk for subsequent cancer development.
Source: Advances and More licensed by HealthDay
